Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on April 3, 2026

Apr. 3, 2026

While Markets Hesitate, ChangeNOW Accelerates: Touching Down in Dubai

Indeterminate EIN Presswire

Apr. 3, 2026

افتتح نهيان بن مبارك قمة قادة مجلس "سامينا" للاتصالات لعام 2026.

Indeterminate EIN Presswire

Apr. 3, 2026

Entrepreneur Karnika E. Yashwant Launches AI Co-Founder Kit to Help Founders Build Startups From Scratch

Indeterminate EIN Presswire

Apr. 3, 2026

Spot AI Named Title Sponsor of Retail Zone at SVIP Experience Center: Redefining the Future of The Security Industry

Indeterminate EIN Presswire

Apr. 3, 2026

Crypto News: AlphaPepe Stage 10 Nearly Sold Out Prior Big Price Rise As XRP Eyes $5 Breakout

Indeterminate GlobeNewswire

Apr. 3, 2026

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Indeterminate GlobeNewswire

Apr. 3, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 3, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 3, 2026

Dubai Businesses Lose Up to 40% of Leads Due to Poor Website Conversion Systems

Indeterminate EIN Presswire

Apr. 3, 2026

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Indeterminate GlobeNewswire

Apr. 3, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 3, 2026

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

Indeterminate GlobeNewswire

Apr. 3, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 3, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Apr. 3, 2026

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 3, 2026

ClimateTech Connect Announces Global Pitch Competition Finalists Ahead of Next Week's Conference

Indeterminate GlobeNewswire

Apr. 3, 2026

Watrfall to Host Investor Webinar on Fan-Funded Film Platform, Backed by Proven Entertainment Leadership

Indeterminate GlobeNewswire

Apr. 3, 2026

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 3, 2026

Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans

Indeterminate GlobeNewswire

Apr. 3, 2026

Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

Indeterminate GlobeNewswire